Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Fabris

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancers|March 19, 2020
Targeting Epigenetic Dependencies in Solid Tumors: Evolutionary Landscape Beyond Germ Layers OriginFrancesca Citron, Linda Fabris
International Review of Cell and Molecular Biology|July 22, 2017
Understanding the Genomic Ultraconservations: T-UCRs and CancerLinda Fabris, George A Calin
Molecular Oncology|February 11, 2016
Circulating free xeno-microRNAs - The new kids on the blockLinda Fabris, George Adrian Calin
Molecular & Cellular Oncology|February 17, 2017
p27kip1: An all-round tumor suppressorBarbara Belletti, Linda Fabris, Gustavo Baldassarre
International Journal of Molecular Sciences|September 17, 2020
Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic LeukemiaLinda Fabris, Jaroslav Juracek, George Calin
Journal of Experimental & Clinical Cancer Research : CR|June 29, 2016
Targeting microRNAs as key modulators of tumor immune responseLaura Paladini, Linda Fabris, Giulia Bottai, et al.
Plos One|March 23, 2011
Role of T198 modification in the regulation of p27(Kip1) protein stability and functionMonica Schiappacassi, Sara Lovisa, Francesca Lovat, et al.
Frontiers in Cell and Developmental Biology|October 12, 2020
Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical BiomarkersDominik A Barth, Rares Drula, Leonie Ott, et al.
Plos One|October 3, 2012
Stathmin is dispensable for tumor onset in miceSara D'Andrea, Stefania Berton, Ilenia Segatto, et al.
European Urology|January 26, 2016
The Potential of MicroRNAs as Prostate Cancer BiomarkersLinda Fabris, Yvonne Ceder, Arul M Chinnaiyan, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancers|March 19, 2020
Targeting Epigenetic Dependencies in Solid Tumors: Evolutionary Landscape Beyond Germ Layers OriginFrancesca Citron, Linda Fabris
International Review of Cell and Molecular Biology|July 22, 2017
Understanding the Genomic Ultraconservations: T-UCRs and CancerLinda Fabris, George A Calin
Molecular Oncology|February 11, 2016
Circulating free xeno-microRNAs - The new kids on the blockLinda Fabris, George Adrian Calin
Molecular & Cellular Oncology|February 17, 2017
p27kip1: An all-round tumor suppressorBarbara Belletti, Linda Fabris, Gustavo Baldassarre
International Journal of Molecular Sciences|September 17, 2020
Non-Coding RNAs as Cancer Hallmarks in Chronic Lymphocytic LeukemiaLinda Fabris, Jaroslav Juracek, George Calin
Journal of Experimental & Clinical Cancer Research : CR|June 29, 2016
Targeting microRNAs as key modulators of tumor immune responseLaura Paladini, Linda Fabris, Giulia Bottai, et al.
Plos One|March 23, 2011
Role of T198 modification in the regulation of p27(Kip1) protein stability and functionMonica Schiappacassi, Sara Lovisa, Francesca Lovat, et al.
Frontiers in Cell and Developmental Biology|October 12, 2020
Circulating Non-coding RNAs in Renal Cell Carcinoma-Pathogenesis and Potential Implications as Clinical BiomarkersDominik A Barth, Rares Drula, Leonie Ott, et al.
Plos One|October 3, 2012
Stathmin is dispensable for tumor onset in miceSara D'Andrea, Stefania Berton, Ilenia Segatto, et al.
European Urology|January 26, 2016
The Potential of MicroRNAs as Prostate Cancer BiomarkersLinda Fabris, Yvonne Ceder, Arul M Chinnaiyan, et al.
Pageof 3